CN113069406A - 一种碳酸面膜及其制备方法 - Google Patents
一种碳酸面膜及其制备方法 Download PDFInfo
- Publication number
- CN113069406A CN113069406A CN202110484032.3A CN202110484032A CN113069406A CN 113069406 A CN113069406 A CN 113069406A CN 202110484032 A CN202110484032 A CN 202110484032A CN 113069406 A CN113069406 A CN 113069406A
- Authority
- CN
- China
- Prior art keywords
- component
- extract
- stirring
- sodium
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 title claims abstract 9
- 238000002360 preparation method Methods 0.000 title abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000001540 sodium lactate Substances 0.000 claims abstract description 32
- 229940005581 sodium lactate Drugs 0.000 claims abstract description 32
- 235000011088 sodium lactate Nutrition 0.000 claims abstract description 32
- 238000002156 mixing Methods 0.000 claims abstract description 31
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 30
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 25
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 25
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 241000588986 Alcaligenes Species 0.000 claims abstract description 17
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 17
- 150000004676 glycans Chemical class 0.000 claims abstract description 17
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 17
- 239000005017 polysaccharide Substances 0.000 claims abstract description 17
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 17
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 17
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 16
- 229960001631 carbomer Drugs 0.000 claims abstract description 16
- 239000004310 lactic acid Substances 0.000 claims abstract description 15
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 15
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 15
- 239000001509 sodium citrate Substances 0.000 claims abstract description 15
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 15
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 14
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 14
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 13
- 229940101267 panthenol Drugs 0.000 claims abstract description 13
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 13
- 239000011619 pantothenol Substances 0.000 claims abstract description 13
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 11
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 11
- 229940032094 squalane Drugs 0.000 claims abstract description 11
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims abstract description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 56
- 235000012907 honey Nutrition 0.000 claims description 27
- 239000012071 phase Substances 0.000 claims description 25
- 239000008367 deionised water Substances 0.000 claims description 24
- 229910021641 deionized water Inorganic materials 0.000 claims description 24
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 24
- 239000008346 aqueous phase Substances 0.000 claims description 23
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 22
- 239000003921 oil Substances 0.000 claims description 21
- 235000019198 oils Nutrition 0.000 claims description 21
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 20
- 229940059958 centella asiatica extract Drugs 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 19
- 238000001816 cooling Methods 0.000 claims description 16
- 230000001815 facial effect Effects 0.000 claims description 16
- 229940057910 shea butter Drugs 0.000 claims description 13
- 229960000541 cetyl alcohol Drugs 0.000 claims description 12
- 230000001804 emulsifying effect Effects 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 11
- 235000021388 linseed oil Nutrition 0.000 claims description 10
- 239000000944 linseed oil Substances 0.000 claims description 10
- 229940078812 myristyl myristate Drugs 0.000 claims description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 10
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 claims description 10
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 10
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 8
- 229940075529 glyceryl stearate Drugs 0.000 claims description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 8
- 229940114926 stearate Drugs 0.000 claims description 8
- 241000857908 Chimonanthus nitens Species 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 241000167550 Centella Species 0.000 claims description 5
- 238000004945 emulsification Methods 0.000 claims description 5
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 claims description 4
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 4
- 229940056318 ceteth-20 Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 229940100459 steareth-20 Drugs 0.000 claims description 4
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 241000721153 Chloranthus japonicus Species 0.000 claims description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 2
- 229940033663 thimerosal Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 230000037394 skin elasticity Effects 0.000 abstract description 5
- 230000002087 whitening effect Effects 0.000 abstract description 5
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 4
- 206010000496 acne Diseases 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 44
- 210000003491 skin Anatomy 0.000 description 24
- 239000001569 carbon dioxide Substances 0.000 description 13
- 229910002092 carbon dioxide Inorganic materials 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 210000001339 epidermal cell Anatomy 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 241000208681 Hamamelis virginiana Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000004520 water soluble gel Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种碳酸面膜及其制备方法，碳酸面膜由成分A和成分B按质量比1:1混合而成；成分A包括卡波姆、乳酸钠、蜂蜜、小苏打、三乙醇胺、积雪草提取物、北美金镂梅提取物、甘草酸二钾等；成分B由水相和油相混合制成，水相包括产碱杆菌多糖类、透明质酸钠、乳酸钠、蜂蜜、泛醇、积雪草提取物、北美金镂梅提取物、甘草酸二钾、柠檬酸钠、乳酸等，油相包括月桂基PEG‑8聚二甲基硅氧烷、角鲨烷、牛油果树果脂等。本发明所得面膜能够保证充分的碳酸分子进入肌肤，促进肌肤新陈代谢，提高血液循环，有效改善肤色暗沉、祛除色斑和痘印，并能实现面膜美白抗菌、滋润修复受损肌肤、舒缓肌肤敏感、增加肌肤弹性、改善皮肤松弛的功效。
Description
技术领域
本发明涉及面膜技术领域，特别是涉及一种碳酸面膜及其制备方法。
背景技术
碳酸面膜是一种新型面膜，与普通水剂面膜不同的是，碳酸面膜不需要无纺布作为载体，这样避免了无纺布对皮肤的刺激。碳酸面膜反应生成的二氧化碳气体，停留在皮肤表面，提高了角质层细胞的二氧化碳含量。由于浓度差，血红细胞将运输更多的氧气至表皮细胞。这样不仅促进了皮肤的血液循环，还增加了表皮细胞的氧气含量，提高了表皮细胞的细胞活性，对肌肤是一种由内向外的改善。然而，目前市面上的碳酸面膜大多是使用碳酸氢钠与柠檬酸反应发泡，在混合后生成二氧化碳气体，在水相基质形成泡沫，但一般情况下泡沫容易破，向空气挥散，使面膜中二氧化碳有效浓度下降，降低美容效果。
发明内容
本发明的目的在于克服上述现有技术的不足，提供一种碳酸面膜及其制备方法，所得面膜能够保证充分的碳酸分子进入肌肤，促进肌肤新陈代谢，提高血液循环，有效改善肤色暗沉、祛除色斑和痘印，并能实现面膜美白抗菌、滋润修复受损肌肤、舒缓肌肤敏感、增加肌肤弹性、改善皮肤松弛的功效。
为了实现上述目的，本发明采用如下技术方案：
一种碳酸面膜，所述碳酸面膜由成分A和成分B按质量比1:1混合而成；
以成分A质量100％计，所述成分A包括2～2.2％的卡波姆、2～2.5％的乳酸钠、2～2.5％的蜂蜜、4～6％的小苏打、5～6％的三乙醇胺、8～10％的积雪草提取物、5～8％的北美金镂梅提取物、0.5～1％的甘草酸二钾、0.4～0.6％的辛酰羟肟酸，余量为去离子水；
所述成分B由水相和油相按质量比4.46～7:1混合制成，以成分B质量100％计，所述水相包括0.3～0.35％的产碱杆菌多糖类、0.05～0.08％的透明质酸钠、2～2.5％的乳酸钠、2～2.5％的蜂蜜、0.5～1％的泛醇、8～10％的积雪草提取物、5～8％的北美金镂梅提取物、0.5～1％的甘草酸二钾、6～9％的柠檬酸钠、6～8％的乳酸、0.4～0.6％的辛酰羟肟酸、38.67～56.75％的去离子水，所述油相包括0.4～1％的月桂基PEG-8聚二甲基硅氧烷、3～4％的角鲨烷、1～2％的亚麻籽油、2～3％的辛酸/葵酸甘油三酯、0.5～0.8％的鲸蜡醇、2.5～2.7％的甘油硬脂酸酯、0.2～0.3％的PEG-75硬脂酸酯、0.2～0.25％的鲸蜡醇聚醚-20、0.2～0.25％的硬脂醇聚醚-20、1.5～2％的肉豆蔻醇肉豆蔻酸酯、1～2％的牛油果树果脂。
以成分A质量100％计，所述成分A包括2％的卡波姆、2％的乳酸钠、2％的蜂蜜、4％的小苏打、5％的三乙醇胺、8％的积雪草提取物、5％的北美金镂梅提取物、0.5％的甘草酸二钾、0.4％的辛酰羟肟酸，余量为去离子水；
所述成分B由水相和油相按质量比1:7混合制成，以成分B质量100％计，所述水相包括0.3％的产碱杆菌多糖类、0.05％的透明质酸钠、2％的乳酸钠、2％的蜂蜜、0.5％的泛醇、8％的积雪草提取物、5％的北美金镂梅提取物、0.5％的甘草酸二钾、6％的柠檬酸钠、6％的乳酸、0.4％的辛酰羟肟酸、56.75％的去离子水，所述油相包括0.4％的月桂基PEG-8聚二甲基硅氧烷、3％的角鲨烷、1％的亚麻籽油、2％的辛酸/葵酸甘油三酯、0.5％的鲸蜡醇、2.5％的甘油硬脂酸酯、0.2％的PEG-75硬脂酸酯、0.2％的鲸蜡醇聚醚-20、0.2％的硬脂醇聚醚-20、1.5％的肉豆蔻醇肉豆蔻酸酯、1％的牛油果树果脂。
一种碳酸面膜的制备方法，包括以下步骤：
(1)将卡波姆、乳酸钠、蜂蜜、小苏打、三乙醇胺、积雪草提取物、北美金镂梅提取物、甘草酸二钾与去离子水按比例混合，搅拌加热至85℃并在该温度下继续搅拌至物料完全溶解，搅拌速率为50转/分钟，之后降温至40℃，加入辛酰羟肟酸搅拌5分钟，再次降温至室温，得到成分A；
(2)将产碱杆菌多糖类、透明质酸钠、乳酸钠、蜂蜜、泛醇、积雪草提取物、北美金镂梅提取物、甘草酸二钾、柠檬酸钠、乳酸、去离子水按比例混合，搅拌加热至80℃并在该温度下继续搅拌至物料完全溶解，得到第一混合物，其中搅拌速率为50转/分钟；
(3)将月桂基PEG-8聚二甲基硅氧烷、角鲨烷、亚麻籽油、辛酸/葵酸甘油三酯、鲸蜡醇、甘油硬脂酸酯、PEG-75硬脂酸酯、鲸蜡醇聚醚-20、硬脂醇聚醚-20、肉豆蔻醇肉豆蔻酸酯、牛油果树果脂混合，搅拌加热至70℃并在该温度下继续搅拌至物料完全溶解，得到油相，其中搅拌速率为50转/分钟；
(4)将油相加入至第一混合物中进行搅拌乳化，乳化搅拌速度控制在4000转/分钟，乳化时间5分钟；
(5)乳化完成后，控制搅拌速度在70转/分钟并逐步降温至40℃，加入辛酰羟肟酸继续搅拌5分钟，降温至室温，得到成分B；
(6)将成分A与成分B按质量比1:1混合均匀，得到碳酸面膜。
所述产碱杆菌多糖类、透明质酸钠、乳酸钠、蜂蜜、泛醇、积雪草提取物、北美金镂梅提取物、甘草酸二钾、柠檬酸钠、乳酸、去离子和辛酰羟肟酸组成成分B的水相。
蜂蜜中含有人体所需的氨基酸、维生素、果糖等有效成分，能够起到排毒养颜、滋润白肤的作用，还能够保存肌肤的弹性。北美金镂梅提取物有舒缓、收敛、抗菌、深层清洁、对抗自由基的功效，具有消炎、镇静安抚肌肤的功能，能够缓和受刺激的皮肤，帮助肌肤再生，防止肌肤衰老。积雪草提取物主要成分积雪草苷对瘢痕成纤维细胞活力有促进作用，与磷脂物质聚合效果很好，对消除青春痘有较明显的作用，对葡萄苷醛酸酶有抑制作用，加之具有抗菌性，能很好地抑制体臭；其可用作生发产品，通过促进细胞活力促使毛发良好生长。在成分A中，乳酸钠、小苏打、甘草酸二钾属于电解质，电解质浓度的微小变化都能引起卡波姆凝胶体系粘度的变化，且电解质浓度越大，卡波姆凝胶体系粘度下降就越显著，使成分A稳定性变差。本发明中，通过成分A各组分的合理配制，控制pH在7.5-8.2，使卡波姆与三乙醇胺、积雪草提取物等形成稳定水溶性凝胶体系，凝胶体系能够吸附北美金缕梅提取物中的有效成分，提升体系稳定性，且蜂蜜的加入能够使凝胶体系形成牛顿与非牛顿流体混合体系，进一步提升成分A的稳定性，并能够在面膜使用过程中，快速释放北美金镂梅提取物、积雪草提取物、蜂蜜、产碱杆菌多糖类、透明质酸钠、牛油果树果脂等有效成分，使有效成分在肌肤停留时间长，药效持久，从而充分发挥北美金镂梅提取物、积雪草提取物、产碱杆菌多糖类、透明质酸钠、牛油果树果脂等物质的协同增效作用，实现面膜美白润肤、祛除色斑和痘印、修复受损肌肤、改善肌肤弹性的功效。另外，面膜使用时，在成分A与成分B混合生成二氧化碳的同时，成分A、成分B中的乳酸钠已与其他成分形成水化膜，能够有效减缓二氧化碳的消散，且反应生成二氧化碳的同时所生成的乳酸钠也能快速与其他成分形成水化膜，从而以两层水化膜的形式进一步减缓二氧化碳的消散，从而使二氧化碳分子有效进入肌肤。
水相与油相混合时，易发生分层、析水等现象，影响体系的稳定性，本发明中，成分B水相中的积雪草提取物、产碱杆菌多糖类、透明质酸钠、蜂蜜形成层状水凝胶物质，能够促进水相与油相的乳化混合，且当成分A与成分B混合后，该层状水凝胶物质能够稳定二氧化碳气泡，减缓二氧化碳消散，进一步改善面膜功效，另外，蜂蜜的加入也能够使水凝胶体系形成牛顿与非牛顿流体混合体，进一步提升成分B的稳定性，北美金镂梅提取物中的有效成分也易被凝胶体系吸附，提升稳定性。
本发明的有益效果是：通过成分A中的碳酸氢钠与成分B中的乳酸反应产生二氧化碳，并利用双重乳酸钠水膜(反应生成的乳酸钠形成的水膜和成分B中事先形成的乳酸钠水膜)及混合物中的凝胶体系减缓二氧化碳的消散，保证充分的碳酸分子进入肌肤，从而促进肌肤新陈代谢，提高血液循环，有效改善肤色暗沉、祛除色斑和痘印；同时通过蜂蜜的添加，分别改善成分A、成分B的稳定性，并能够有效促进北美金镂梅提取物、积雪草提取物、产碱杆菌多糖类、透明质酸钠、牛油果树果脂等有效成分的释放吸收，从而发挥各有效成分间的协同增效作用，实现面膜美白抗菌、滋润修复受损肌肤、舒缓肌肤敏感、增加肌肤弹性、改善皮肤松弛的功效，。
具体实施方式
下面结合具体实施方式对本发明作进一步描述：
实施例1
碳酸面膜，由成分A和成分B按质量比1:1混合而成；
以成分A质量100％计，所述成分A包括2％的卡波姆、2％的乳酸钠、2％的蜂蜜、4％的小苏打、5％的三乙醇胺、8％的积雪草提取物、5％的北美金镂梅提取物、0.5％的甘草酸二钾、0.4％的辛酰羟肟酸，余量为去离子水；
所述成分B由水相和油相按质量比7:1混合制成，以成分B质量100％计，所述水相包括0.3％的产碱杆菌多糖类、0.05％的透明质酸钠、2％的乳酸钠、2％的蜂蜜、0.5％的泛醇、8％的积雪草提取物、5％的北美金镂梅提取物、0.5％的甘草酸二钾、6％的柠檬酸钠、6％的乳酸、0.4％的辛酰羟肟酸、56.75％的去离子水，所述油相包括0.4％的月桂基PEG-8聚二甲基硅氧烷、3％的角鲨烷、1％的亚麻籽油、2％的辛酸/葵酸甘油三酯、0.5％的鲸蜡醇、2.5％的甘油硬脂酸酯、0.2％的PEG-75硬脂酸酯、0.2％的鲸蜡醇聚醚-20、0.2％的硬脂醇聚醚-20、1.5％的肉豆蔻醇肉豆蔻酸酯、1％的牛油果树果脂。
碳酸面膜的制备方法，包括以下步骤：
(1)将卡波姆、乳酸钠、蜂蜜、小苏打、三乙醇胺、积雪草提取物、北美金镂梅提取物、甘草酸二钾与去离子水按上述比例混合，搅拌加热至85℃并在该温度下继续搅拌至物料完全溶解，搅拌速率为50转/分钟，之后降温至40℃，加入辛酰羟肟酸搅拌5分钟，再次降温至室温，得到成分A；
(2)将产碱杆菌多糖类、透明质酸钠、乳酸钠、蜂蜜、泛醇、积雪草提取物、北美金镂梅提取物、甘草酸二钾、柠檬酸钠、乳酸、去离子水按上述比例混合，搅拌加热至80℃并在该温度下继续搅拌至物料完全溶解，得到第一混合物，其中搅拌速率为50转/分钟；
(3)将月桂基PEG-8聚二甲基硅氧烷、角鲨烷、亚麻籽油、辛酸/葵酸甘油三酯、鲸蜡醇、甘油硬脂酸酯、PEG-75硬脂酸酯、鲸蜡醇聚醚-20、硬脂醇聚醚-20、肉豆蔻醇肉豆蔻酸酯、牛油果树果脂混合，搅拌加热至70℃并在该温度下继续搅拌至物料完全溶解，得到油相，其中搅拌速率为50转/分钟；
(4)将油相加入至第一混合物中进行搅拌乳化，乳化搅拌速度控制在4000转/分钟，乳化时间5分钟；
(5)乳化完成后，控制搅拌速度在70转/分钟并逐步降温至40℃，加入辛酰羟肟酸继续搅拌5分钟，降温至室温，得到成分B；
(6)将成分A与成分B按质量比1:1混合均匀，得到碳酸面膜。
实施例2
碳酸面膜，由成分A和成分B按质量比1:1混合而成；
以成分A质量100％计，所述成分A包括2.2％的卡波姆、2.5％的乳酸钠、2.5％的蜂蜜、6％的小苏打、6％的三乙醇胺、10％的积雪草提取物、8％的北美金镂梅提取物、1％的甘草酸二钾、0.6％的辛酰羟肟酸，余量为去离子水；
所述成分B由水相和油相按质量比4.46:1混合制成，以成分B质量100％计，所述水相包括0.35％的产碱杆菌多糖类、0.08％的透明质酸钠、2.5％的乳酸钠、2.5％的蜂蜜、1％的泛醇、10％的积雪草提取物、8％的北美金镂梅提取物、1％的甘草酸二钾、9％的柠檬酸钠、8％的乳酸、0.6％的辛酰羟肟酸、38.67％的去离子水，所述油相包括1％的月桂基PEG-8聚二甲基硅氧烷、4％的角鲨烷、2％的亚麻籽油、3％的辛酸/葵酸甘油三酯、0.8％的鲸蜡醇、2.7％的甘油硬脂酸酯、0.3％的PEG-75硬脂酸酯、0.25％的鲸蜡醇聚醚-20、0.25％的硬脂醇聚醚-20、2％的肉豆蔻醇肉豆蔻酸酯、2％的牛油果树果脂。
碳酸面膜的制备方法，包括以下步骤：
(1)将卡波姆、乳酸钠、蜂蜜、小苏打、三乙醇胺、积雪草提取物、北美金镂梅提取物、甘草酸二钾与去离子水按上述比例混合，搅拌加热至85℃并在该温度下继续搅拌至物料完全溶解，搅拌速率为50转/分钟，之后降温至40℃，加入辛酰羟肟酸搅拌5分钟，再次降温至室温，得到成分A；
(2)将产碱杆菌多糖类、透明质酸钠、乳酸钠、蜂蜜、泛醇、积雪草提取物、北美金镂梅提取物、甘草酸二钾、柠檬酸钠、乳酸、去离子水按上述比例混合，搅拌加热至80℃并在该温度下继续搅拌至物料完全溶解，得到第一混合物，其中搅拌速率为50转/分钟；
(3)将月桂基PEG-8聚二甲基硅氧烷、角鲨烷、亚麻籽油、辛酸/葵酸甘油三酯、鲸蜡醇、甘油硬脂酸酯、PEG-75硬脂酸酯、鲸蜡醇聚醚-20、硬脂醇聚醚-20、肉豆蔻醇肉豆蔻酸酯、牛油果树果脂混合，搅拌加热至70℃并在该温度下继续搅拌至物料完全溶解，得到油相，其中搅拌速率为50转/分钟；
(4)将油相加入至第一混合物中进行搅拌乳化，乳化搅拌速度控制在4000转/分钟，乳化时间5分钟；
(5)乳化完成后，控制搅拌速度在70转/分钟并逐步降温至40℃，加入辛酰羟肟酸继续搅拌5分钟，降温至室温，得到成分B；
(6)将成分A与成分B按质量比1:1混合均匀，得到碳酸面膜。
实施例3～8
分别按照表1所示配比及实施例1的制备方法制备碳酸面膜。
表1实施例3～8的碳酸面膜原料配比
对比例1
按实施例1的方法进行对比实验，不同之处在于成分A、成分B水相中不添加蜂蜜。
对比例2
按实施例1的方法进行对比实验，不同之处在于成分A中的乳酸钠改为柠檬酸钠，成分B水相中乳酸改为柠檬酸、乳酸钠改为柠檬酸钠。
对比例3
按实施例1的方法进行对比实验，不同之处在于成分A中卡波姆的含量为1.5％，除去离子水外，其他组分不变。
对比例4
按实施例1的方法进行对比实验，不同之处在于成分A中卡波姆的含量为2.8％，除去离子水外，其他组分不变。
分别对各实施例的成分A、成分B进行稳定性及抑菌性测试，结果如表1所示。
表1
随机筛选30名志愿者，对各实施例及各对比例制备的面膜进行性能测试，试验结果如表2所示。
表2
以上所述仅为本发明的较佳实施例，并不用以限制本发明，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.一种碳酸面膜，其特征在于：所述碳酸面膜由成分A和成分B按质量比1:1混合而成；
以成分A质量100％计，所述成分A包括2～2.2％的卡波姆、2～2.5％的乳酸钠、2～2.5％的蜂蜜、4～6％的小苏打、5～6％的三乙醇胺、8～10％的积雪草提取物、5～8％的北美金镂梅提取物、0.5～1％的甘草酸二钾、0.4～0.6％的辛酰羟肟酸，余量为去离子水；
所述成分B由水相和油相按质量比4.46～7:1混合制成，以成分B质量100％计，所述水相包括0.3～0.35％的产碱杆菌多糖类、0.05～0.08％的透明质酸钠、2～2.5％的乳酸钠、2～2.5％的蜂蜜、0.5～1％的泛醇、8～10％的积雪草提取物、5～8％的北美金镂梅提取物、0.5～1％的甘草酸二钾、6～9％的柠檬酸钠、6～8％的乳酸、0.4～0.6％的辛酰羟肟酸、38.67～56.75％的去离子水，所述油相包括0.4～1％的月桂基PEG-8聚二甲基硅氧烷、3～4％的角鲨烷、1～2％的亚麻籽油、2～3％的辛酸/葵酸甘油三酯、0.5～0.8％的鲸蜡醇、2.5～2.7％的甘油硬脂酸酯、0.2～0.3％的PEG-75硬脂酸酯、0.2～0.25％的鲸蜡醇聚醚-20、0.2～0.25％的硬脂醇聚醚-20、1.5～2％的肉豆蔻醇肉豆蔻酸酯、1～2％的牛油果树果脂。
2.如权利要求1所述一种碳酸面膜，其特征在于：以成分A质量100％计，所述成分A包括2％的卡波姆、2％的乳酸钠、2％的蜂蜜、4％的小苏打、5％的三乙醇胺、8％的积雪草提取物、5％的北美金镂梅提取物、0.5％的甘草酸二钾、0.4％的辛酰羟肟酸，余量为去离子水；
所述成分B由水相和油相按质量比1:7混合制成，以成分B质量100％计，所述水相包括0.3％的产碱杆菌多糖类、0.05％的透明质酸钠、2％的乳酸钠、2％的蜂蜜、0.5％的泛醇、8％的积雪草提取物、5％的北美金镂梅提取物、0.5％的甘草酸二钾、6％的柠檬酸钠、6％的乳酸、0.4％的辛酰羟肟酸、56.75％的去离子水，所述油相包括0.4％的月桂基PEG-8聚二甲基硅氧烷、3％的角鲨烷、1％的亚麻籽油、2％的辛酸/葵酸甘油三酯、0.5％的鲸蜡醇、2.5％的甘油硬脂酸酯、0.2％的PEG-75硬脂酸酯、0.2％的鲸蜡醇聚醚-20、0.2％的硬脂醇聚醚-20、1.5％的肉豆蔻醇肉豆蔻酸酯、1％的牛油果树果脂。
3.一种如权利要求1-2中任意一项所述碳酸面膜的制备方法，其特征在于：包括以下步骤：
(1)将卡波姆、乳酸钠、蜂蜜、小苏打、三乙醇胺、积雪草提取物、北美金镂梅提取物、甘草酸二钾与去离子水按比例混合，搅拌加热至85℃并在该温度下继续搅拌至物料完全溶解，搅拌速率为50转/分钟，之后降温至40℃，加入辛酰羟肟酸搅拌5分钟，再次降温至室温，得到成分A；
(2)将产碱杆菌多糖类、透明质酸钠、乳酸钠、蜂蜜、泛醇、积雪草提取物、北美金镂梅提取物、甘草酸二钾、柠檬酸钠、乳酸、去离子水按比例混合，搅拌加热至80℃并在该温度下继续搅拌至物料完全溶解，得到第一混合物，其中搅拌速率为50转/分钟；
(3)将月桂基PEG-8聚二甲基硅氧烷、角鲨烷、亚麻籽油、辛酸/葵酸甘油三酯、鲸蜡醇、甘油硬脂酸酯、PEG-75硬脂酸酯、鲸蜡醇聚醚-20、硬脂醇聚醚-20、肉豆蔻醇肉豆蔻酸酯、牛油果树果脂混合，搅拌加热至70℃并在该温度下继续搅拌至物料完全溶解，得到油相，其中搅拌速率为50转/分钟；
(4)将油相加入至第一混合物中进行搅拌乳化，乳化搅拌速度控制在4000转/分钟，乳化时间5分钟；
(5)乳化完成后，控制搅拌速度在70转/分钟并逐步降温至40℃，加入辛酰羟肟酸继续搅拌5分钟，降温至室温，得到成分B；
(6)将成分A与成分B按质量比1:1混合均匀，得到碳酸面膜。
4.如权利要求3所述一种碳酸面膜的制备方法，其特征在于：所述产碱杆菌多糖类、透明质酸钠、乳酸钠、蜂蜜、泛醇、积雪草提取物、北美金镂梅提取物、甘草酸二钾、柠檬酸钠、乳酸、去离子和辛酰羟肟酸组成成分B的水相。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110484032.3A CN113069406A (zh) | 2021-04-30 | 2021-04-30 | 一种碳酸面膜及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110484032.3A CN113069406A (zh) | 2021-04-30 | 2021-04-30 | 一种碳酸面膜及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113069406A true CN113069406A (zh) | 2021-07-06 |
Family
ID=76616565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110484032.3A Pending CN113069406A (zh) | 2021-04-30 | 2021-04-30 | 一种碳酸面膜及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113069406A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102309437A (zh) * | 2010-06-29 | 2012-01-11 | 森图容有限公司 | 含有二氧化碳的粘性化妆品组合物 |
| CN104546627A (zh) * | 2013-10-17 | 2015-04-29 | 刘俊 | 一种柠檬蜂蜜面膜及其制作方法 |
| JP3218013U (ja) * | 2018-07-05 | 2018-09-13 | ゲィリー ツァワーＧａｒｒｙ Ｔｓａｕｒ | スキンケアマスク |
| CN109010083A (zh) * | 2018-09-07 | 2018-12-18 | 广州华玺生物科技有限公司 | 一种具有两亲物质构成的层状结构体的二氧化碳复合面膜组合物及其制备方法 |
| CN109077973A (zh) * | 2018-08-25 | 2018-12-25 | 广东芭薇生物科技股份有限公司 | 一种两剂碳酸发泡面膜及其制备方法与使用方法 |
| CN111840199A (zh) * | 2020-09-11 | 2020-10-30 | 遵义医科大学 | 一种蜂蜜面膜及其制备方法 |
-
2021
- 2021-04-30 CN CN202110484032.3A patent/CN113069406A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102309437A (zh) * | 2010-06-29 | 2012-01-11 | 森图容有限公司 | 含有二氧化碳的粘性化妆品组合物 |
| CN104546627A (zh) * | 2013-10-17 | 2015-04-29 | 刘俊 | 一种柠檬蜂蜜面膜及其制作方法 |
| JP3218013U (ja) * | 2018-07-05 | 2018-09-13 | ゲィリー ツァワーＧａｒｒｙ Ｔｓａｕｒ | スキンケアマスク |
| CN109077973A (zh) * | 2018-08-25 | 2018-12-25 | 广东芭薇生物科技股份有限公司 | 一种两剂碳酸发泡面膜及其制备方法与使用方法 |
| CN109010083A (zh) * | 2018-09-07 | 2018-12-18 | 广州华玺生物科技有限公司 | 一种具有两亲物质构成的层状结构体的二氧化碳复合面膜组合物及其制备方法 |
| CN111840199A (zh) * | 2020-09-11 | 2020-10-30 | 遵义医科大学 | 一种蜂蜜面膜及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 上海诚美化妆品有限公司: "missshop 碳酸面膜（蜂蜜）", 《国产普通化妆品备案信息》 * |
| 潘卫三等: "《工业药剂学》", 31 December 2019, 中国医药科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106109296B (zh) | 一种保湿精华水及其制备方法 | |
| CN108567638B (zh) | 一种具有表皮修复功能的保湿敷料 | |
| WO2014117316A1 (zh) | 多功能芦荟胶及其制备方法 | |
| CN112353714A (zh) | 一种覆膜酵母发酵物的制备方法及其应用 | |
| CN111214427B (zh) | 一种无酸焕肤组合物及制备方法和含该组合物的精华液 | |
| CN111419774A (zh) | 一种基于纤维素纤维的高保湿面膜及其制备方法 | |
| CN107095843A (zh) | 一种含红茶菌的面膜 | |
| CN108420757A (zh) | 一种保湿水及其制备工艺 | |
| CN1270688C (zh) | 一种乳化盐型洁肤用品及其制备方法 | |
| CN112569129A (zh) | 一种酸性护肤水凝胶配方及其制备方法 | |
| CN107854403A (zh) | 一种洁净保湿润肤霜 | |
| CN108354864B (zh) | 一种具有美白保湿功效的乳液的制备方法 | |
| CN114617835A (zh) | 一种两剂diy膏霜面膜及其制备方法 | |
| CN114099387A (zh) | 一种玫瑰美白保湿精华乳及其制备方法 | |
| CN114225007A (zh) | 一种用于修复浅表性创面的乳清蛋白喷雾剂及制备方法 | |
| CN112043657B (zh) | 一种高保湿滋养面膜及其制备方法 | |
| CN113069406A (zh) | 一种碳酸面膜及其制备方法 | |
| JP2003034612A (ja) | 炭酸経皮吸収用組成物、その用途及び使用方法 | |
| CN111358710A (zh) | 一种保湿舒缓阿胶面霜及其制备方法 | |
| CN114569507A (zh) | 一种保湿乳液及其制备方法 | |
| CN115429738A (zh) | 一种祛痘修护焕活精华液及其制备方法 | |
| CN115137667A (zh) | 一种具有促渗功效的化妆品组合物及其应用 | |
| CN113384488A (zh) | 一种补水保湿的水粉分离双相面膜的配方及其制备方法 | |
| CN112675071A (zh) | 一种羊毛角蛋白冻干面膜及其制备方法和应用 | |
| CN112656742A (zh) | 一种葡萄籽红酒面膜泥及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: Room 101, No. 10, Puxin Commercial Street, Shipai Town, Dongguan City, Guangdong Province, 523000 Applicant after: DONGGUAN CITY YAN COSMETICS Co.,Ltd. Address before: 523000 Puxin Industrial Zone, Puxin Village, Shipai Town, Dongguan City, Guangdong Province Applicant before: DONGGUAN CITY YAN COSMETICS Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210706 |
|
| RJ01 | Rejection of invention patent application after publication |